CBD shows promise for severe behavioral issues in kids with intellectual disability
NCT ID NCT04821856
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tested whether a purified form of cannabidiol (CBD) can reduce severe behavioral problems in children aged 6 to 18 with intellectual disability. Over 8 weeks, 132 participants received either CBD or a placebo. The goal was to see if CBD could ease symptoms like irritability and aggression, offering a potential new option for families struggling with these challenging behaviors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTELLECTUAL DISABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Monash Children's Hospital
Clayton, Victoria, 3168, Australia
-
Royal Children's Hospital / Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
The Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.